SGLT2 Inhibition for CKD and Cardiovascular Disease in Type 2 Diabetes: Report of a Scientific Workshop Sponsored by the National Kidney Foundation - Tuttle, KR; Brosius, FC, 3rd; Cavender, MA (Am J Kidney Dis, 2020)